Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroglia in the autistic brain: evidence from a preclinical model
Maria Rosanna Bronzuoli, Roberta Facchinetti, Davide Ingrassia, et al.
Molecular Autism (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

A standardized social preference protocol for measuring social deficits in mouse models of autism
Benjamin Rein, Kaijie Ma, Zhen Yan
Nature Protocols (2020) Vol. 15, Iss. 10, pp. 3464-3477
Open Access | Times Cited: 153
Impaired calcium signaling in astrocytes modulates autism spectrum disorder-like behaviors in mice
Qian Wang, Ying Kong, Ding-Yu Wu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 104
Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
María de los Ángeles Robinson‐Agramonte, Elena Noris García, Jarasca Fraga Guerra, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3033-3033
Open Access | Times Cited: 92
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats
Erica Zamberletti, Marina Gabaglio, Marie Woolley-Roberts, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 82
Role of Oligodendrocytes and Myelin in the Pathophysiology of Autism Spectrum Disorder
Alma Y. Gálvez‐Contreras, David Zárate-López, Ana Laura Torres-Chávez, et al.
Brain Sciences (2020) Vol. 10, Iss. 12, pp. 951-951
Open Access | Times Cited: 81
Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment
Abdoh Taleb, Wen Lin, Xiang Xu, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111322-111322
Open Access | Times Cited: 65
Microglia and Astroglia—The Potential Role in Neuroinflammation Induced by Pre- and Neonatal Exposure to Lead (Pb)
Magdalena Gąssowska-Dobrowolska, Mikołaj Chlubek, Agnieszka Kolasa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9903-9903
Open Access | Times Cited: 26
Insights into the structure and function of the hippocampus: implications for the pathophysiology and treatment of autism spectrum disorder
Junzi Long, Hui Li, Ying Liu, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 13
Reward-Related Behavioral, Neurochemical and Electrophysiological Changes in a Rat Model of Autism Based on Prenatal Exposure to Valproic Acid
Sara Schiavi, Daniela Iezzi, Antonia Manduca, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 73
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder
David Zárate-López, Ana Laura Torres-Chávez, Alma Y. Gálvez‐Contreras, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 2, pp. 260-289
Open Access | Times Cited: 19
Prenatal Exposure to Valproic Acid Affects Microglia and Synaptic Ultrastructure in a Brain-Region-Specific Manner in Young-Adult Male Rats: Relevance to Autism Spectrum Disorders
Magdalena Gąssowska-Dobrowolska, Magdalena Cieślik, Grzegorz A. Czapski, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3576-3576
Open Access | Times Cited: 48
Astrocyte Function Is Affected by Aging and Not Alzheimer’s Disease: A Preliminary Investigation in Hippocampi of 3xTg-AD Mice
Maria Rosanna Bronzuoli, Roberta Facchinetti, Marta Valenza, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 45
5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats
Kazuya Matsuo, Yasushi Yabuki, Kohji Fukunaga
Neuropharmacology (2020) Vol. 168, pp. 107975-107975
Closed Access | Times Cited: 44
Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study
Esraa M. Elnahas, Sally A. Abuelezz, Magda I. Mohamad, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 108, pp. 110185-110185
Closed Access | Times Cited: 41
Primary cilia signaling in astrocytes mediates development and regional-specific functional specification
Lizheng Wang, Qianqian Guo, Sandesh Acharya, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 9, pp. 1708-1720
Closed Access | Times Cited: 4
The potential ameliorative effect of mesenchymal stem cells-derived exosomes on cerebellar histopathology and their modifying role on PI3k-mTOR signaling in rat model of autism spectrum disorder
Raghda Elsherif, Amel M.M. Abdel-Hafez, Ola A. Hussein, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 1
Closed Access
Involvement of disulfidptosis in the pathophysiology of autism spectrum disorder
Yutong Liu, Yaqi Sun, Anjie Chen, et al.
Life Sciences (2025) Vol. 369, pp. 123531-123531
Closed Access
BEHAVIORAL AND TRANSCRIPTOMIC EFFECTS OF A NOVEL CANNABINOID ON A RAT VALPROIC ACID MODEL OF AUTISM
Sally Loomis, Dylan E. Da Silva, Ranjev Savopoulos, et al.
Neuropharmacology (2025), pp. 110450-110450
Closed Access
Astroglia in Autism Spectrum Disorder
Kinga Gzieło, Agnieszka Nikiforuk
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11544-11544
Open Access | Times Cited: 28
A CCR5 antagonist, maraviroc, alleviates neural circuit dysfunction and behavioral disorders induced by prenatal valproate exposure
Yasuhiro Ishihara, Tatsuya Honda, Nami Ishihara, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 19
Looking for a Treatment for the Early Stage of Alzheimer’s Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin
Roberta Facchinetti, Marta Valenza, Maria Rosanna Bronzuoli, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3802-3802
Open Access | Times Cited: 30
Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story
Emilia Carbone, Antonia Manduca, Claudia Cacchione, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 121, pp. 128-143
Closed Access | Times Cited: 29
Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
Cássio Morais Loss, Lucas Teodoro, Gabriela Doná Rodrigues, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 23
Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges
Chiara Villa, Romina Combi, Donatella Conconi, et al.
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 280-280
Open Access | Times Cited: 23
The putative etiology and prevention of autism
Gary Steinman
Progress in molecular biology and translational science (2020), pp. 1-34
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top